KRT6B (Keratin, type II cytoskeletal 6B) variants and mutations
KRT6B (also known as Keratin, type II cytoskeletal 6B) is a human protein-coding gene encoding a keratin, type II cytoskeletal 6B protein. It contributes to stress-responsive keratin networks in nail, palmoplantar, and other specialized epithelia. Dominant pathogenic variants can cause pachyonychia congenita with nail dystrophy, painful keratoderma, and variable oral or follicular findings. This analysis covers 1,119 KRT6B variants and mutations. Of these, 82% have computational variant effect predictions. Disease context includes pachyonychia congenita 4, pachyonychia congenita, and facial nerve disorder. Example KRT6B variants include A2T, T4I, and S5T.
Variant analysis overview
- Gene: KRT6B
- Protein: Keratin, type II cytoskeletal 6B
- UniProt accession: P04259
- Organism: Homo sapiens
- Variants analyzed: 1119
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 873 unspecified-consequence records; 1 stop retained variant; 11 frameshift variants; 116 synonymous variants; 106 missense variants; 5 in-frame deletions; 3 splice-region variants; 4 stop-gained variants; 1 in-frame insertions; 2 substitution
- Prediction scores: 920 variants have prediction scores (82% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: pachyonychia congenita 4, pachyonychia congenita, facial nerve disorder, hereditary disease, diabetic kidney disease, urolithiasis, alcohol drinking, bladder transitional cell carcinoma, non-small cell lung carcinoma, breast carcinoma, Ankyloblepharon - ectodermal defects - cleft lip/palate, Kindler syndrome.
Protein structure and variant hotspots
- Protein features: 1 domains; 1 post-translational modification sites.
- Structural context: 616 variants have structural context.
- PTM context: 1 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable KRT6B variants
Examples include A2T, T4I, S5T, T6A, T6I, T6N, T6P, T7I. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2T (p.Ala2Thr), gnomAD rs1277037321, REVEL 0.15, CADD 8.82
- T4I (p.Thr4Ile), ExAC rs762438614, gnomAD rs762438614, REVEL 0.02, CADD 9.61
- S5T (p.Ser5Thr), gnomAD rs1363723036, REVEL 0.03, CADD 14.90
- T6A (p.Thr6Ala), ExAC rs752271878, gnomAD rs752271878, REVEL 0.01, CADD 22.90
- T6I (p.Thr6Ile), ExAC rs764803667, TOPMed rs764803667, gnomAD rs764803667, REVEL 0.04, CADD 16.00
- T6N (p.Thr6Asn), ExAC rs764803667, TOPMed rs764803667, gnomAD rs764803667, REVEL 0.09, CADD 22.50
- T6P (p.Thr6Pro), ExAC rs752271878, gnomAD rs752271878
- T7I (p.Thr7Ile), ExAC rs759200378, TOPMed rs759200378, gnomAD rs759200378, REVEL 0.05, CADD 10.40
- T7N (p.Thr7Asn), ExAC rs759200378, TOPMed rs759200378, gnomAD rs759200378, REVEL 0.08, CADD 14.00
- T7P (p.Thr7Pro), Ensembl rs1592171489
- I8N (p.Ile8Asn), ExAC rs200240023, TOPMed rs200240023, gnomAD rs200240023, REVEL 0.09, CADD 19.90, Uncertain significance, Inborn genetic diseases
- I8T (p.Ile8Thr), ExAC rs200240023, TOPMed rs200240023, gnomAD rs200240023, REVEL 0.10, CADD 18.40, Uncertain significance
- R9G (p.Arg9Gly), Ensembl rs1592171481
- R9S (p.Arg9Ser), TOPMed rs1471243579, gnomAD rs1471243579, REVEL 0.05, CADD 15.20, Uncertain significance, Inborn genetic diseases
- S10N (p.Ser10Asn), TOPMed rs1940416711
- S10R (p.Ser10Arg), 1000Genomes rs561690979, ExAC rs561690979, gnomAD rs561690979, REVEL 0.05, CADD 20.60, Uncertain significance, Inborn genetic diseases
- H11N (p.His11Asn), Ensembl rs922395687, REVEL 0.06, CADD 15.30
- H11P (p.His11Pro), TOPMed rs1940416594, gnomAD rs1940416594
- H11Q (p.His11Gln), gnomAD rs1192635915, REVEL 0.07, CADD 3.42
- H11R (p.His11Arg), TOPMed rs1940416594, gnomAD rs1940416594, REVEL 0.03, CADD 17.60
- S14R (p.Ser14Arg), gnomAD rs1426806737, REVEL 0.14, CADD 21.80
- S14T (p.Ser14Thr), Ensembl rs2121514434
- R15C (p.Arg15Cys), rs772519522, ExAC rs772519522, TOPMed rs772519522, gnomAD rs772519522, REVEL 0.07, CADD 21.50, Variant assessed as somatic; moderate impact.
- R15H (p.Arg15His), ExAC rs779144610, gnomAD rs779144610, REVEL 0.03, CADD 1.38, Likely benign, Inborn genetic diseases
- R15L (p.Arg15Leu), ExAC rs779144610, gnomAD rs779144610, REVEL 0.09, CADD 7.51, Likely benign
- R15S (p.Arg15Ser), ExAC rs772519522, TOPMed rs772519522, gnomAD rs772519522, REVEL 0.07, CADD 22.00
- R16L (p.Arg16Leu), ExAC rs749556525, TOPMed rs749556525, gnomAD rs749556525, Uncertain significance
- R16P (p.Arg16Pro), ExAC rs749556525, TOPMed rs749556525, gnomAD rs749556525, REVEL 0.22, CADD 17.70, Uncertain significance
- R16Q (p.Arg16Gln), rs749556525, ClinGen CA6580960, ClinVar RCV003361751, ExAC rs749556525, REVEL 0.10, CADD 17.40, Uncertain significance, Inborn genetic diseases
- R16W (p.Arg16Trp), ExAC rs768946287, TOPMed rs768946287, gnomAD rs768946287, REVEL 0.27, CADD 16.60, Uncertain significance, Inborn genetic diseases
- G17D (p.Gly17Asp), ExAC rs757055827, TOPMed rs757055827, gnomAD rs757055827, REVEL 0.14, CADD 17.90
- G17S (p.Gly17Ser), NCI-TCGA Cosmic COSV5288, REVEL 0.10, CADD 13.60, Variant assessed as somatic; moderate impact.
- G17V (p.Gly17Val), ExAC rs757055827, TOPMed rs757055827, gnomAD rs757055827, REVEL 0.08, CADD 17.50
- F18I (p.Phe18Ile), ExAC rs751372178, gnomAD rs751372178, REVEL 0.45, CADD 24.10
- S19G (p.Ser19Gly), gnomAD rs1250691028, REVEL 0.26, CADD 22.30
- S19I (p.Ser19Ile), TOPMed rs1224666539, gnomAD rs1224666539, REVEL 0.34, CADD 19.00
- S19T (p.Ser19Thr), TOPMed rs1224666539, gnomAD rs1224666539
- A20D (p.Ala20Asp), ESP rs374567840, ExAC rs374567840, gnomAD rs374567840
- A20T (p.Ala20Thr), TOPMed rs1278183872
- A20V (p.Ala20Val), ESP rs374567840, ExAC rs374567840, gnomAD rs374567840, REVEL 0.11, CADD 19.10
- N21D (p.Asn21Asp), Ensembl rs201864717, REVEL 0.17, CADD 2.88
- N21S (p.Asn21Ser), rs428894, ClinGen CA6580955, ClinVar RCV001731071, ClinVar RCV003976123, REVEL 0.14, CADD 8.96, Benign, Pachyonychia congenita 4; not provided
- N21T (p.Asn21Thr), 1000Genomes rs428894, ExAC rs428894, gnomAD rs428894, Benign
- R24S (p.Arg24Ser), ExAC rs764749883, gnomAD rs764749883, REVEL 0.20, CADD 12.10, Uncertain significance, Inborn genetic diseases
- L25F (p.Leu25Phe), ExAC rs759087767, TOPMed rs759087767, gnomAD rs759087767, REVEL 0.19, CADD 7.54, Uncertain significance, Inborn genetic diseases
- L25I (p.Leu25Ile), ExAC rs759087767, TOPMed rs759087767, gnomAD rs759087767, REVEL 0.13, CADD 3.23
- L25R (p.Leu25Arg), TOPMed rs1483320586
- P26L (p.Pro26Leu), TOPMed rs1454903643, gnomAD rs1454903643, REVEL 0.23, CADD 23.60
- G27V (p.Gly27Val), TOPMed rs1940415442, REVEL 0.13, CADD 17.10
- V28A (p.Val28Ala), Ensembl rs1592171429
- V28I (p.Val28Ile), rs761093716, NCI-TCGA Cosmic COSV5288, ExAC rs761093716, gnomAD rs761093716, REVEL 0.12, CADD 8.22, Variant assessed as somatic; moderate impact.
- S29I (p.Ser29Ile), NCI-TCGA Cosmic COSV5288, Variant assessed as somatic; moderate impact.
- S29R (p.Ser29Arg), ExAC rs773449867, gnomAD rs773449867, REVEL 0.24, CADD 19.20
- R30C (p.Arg30Cys), ESP rs368410373, ExAC rs368410373, TOPMed rs368410373, gnomAD rs368410373, REVEL 0.37, CADD 23.90, Uncertain significance, Inborn genetic diseases
- R30H (p.Arg30His), rs374275504, NCI-TCGA Cosmic COSV9936, ESP rs374275504, ExAC rs374275504, REVEL 0.07, CADD 14.00, Variant assessed as somatic; moderate impact.
- R30L (p.Arg30Leu), ESP rs374275504, ExAC rs374275504, TOPMed rs374275504, gnomAD rs374275504, REVEL 0.15, CADD 14.30
- S31P (p.Ser31Pro), ExAC rs768829710, TOPMed rs768829710, gnomAD rs768829710, REVEL 0.19, CADD 20.80, Uncertain significance, Inborn genetic diseases
- S31Y (p.Ser31Tyr), ExAC rs749431471, gnomAD rs749431471, REVEL 0.14, CADD 18.00
- G32D (p.Gly32Asp), gnomAD rs1394967245, REVEL 0.14, CADD 23.50
- G32V (p.Gly32Val), NCI-TCGA Cosmic COSV9936, Variant assessed as somatic; moderate impact.
- F33S (p.Phe33Ser), gnomAD rs1461581307, REVEL 0.52, CADD 27.60
- S34G (p.Ser34Gly), 1000Genomes rs548276151, ExAC rs548276151, gnomAD rs548276151, REVEL 0.25, CADD 23.90
- S35N (p.Ser35Asn), gnomAD rs1341343109, REVEL 0.13, CADD 18.20
- S35R (p.Ser35Arg), ExAC rs769979285, gnomAD rs769979285, REVEL 0.13, CADD 8.25
- I36V (p.Ile36Val), ExAC rs404970, gnomAD rs404970, REVEL 0.03, CADD 0.05, Likely benign, Inborn genetic diseases
- V38L (p.Val38Leu), TOPMed rs1316716310, gnomAD rs1316716310
- V38M (p.Val38Met), TOPMed rs1316716310, gnomAD rs1316716310, REVEL 0.14, CADD 8.76
- S39C (p.Ser39Cys), TOPMed rs1940414530, Uncertain significance, Inborn genetic diseases
- R40C (p.Arg40Cys), rs758283387, ClinGen CA6580937, ClinVar RCV003219824, ExAC rs758283387, REVEL 0.43, CADD 23.30, Uncertain significance, Inborn genetic diseases
- R40H (p.Arg40His), 1000Genomes rs139304263, ESP rs139304263, ExAC rs139304263, gnomAD rs139304263, REVEL 0.36, CADD 18.30, Uncertain significance, Inborn genetic diseases
- R40P (p.Arg40Pro), 1000Genomes rs139304263, ESP rs139304263, ExAC rs139304263, gnomAD rs139304263, REVEL 0.50, CADD 23.60, Uncertain significance
- S41P (p.Ser41Pro), Ensembl rs1940414257, REVEL 0.30, CADD 21.70
- R42S (p.Arg42Ser), NCI-TCGA Cosmic COSV9936, REVEL 0.09, CADD 13.20, Variant assessed as somatic; moderate impact.
- G43D (p.Gly43Asp), ExAC rs755733133, TOPMed rs755733133, gnomAD rs755733133, REVEL 0.69, CADD 23.60
- G43R (p.Gly43Arg), ExAC rs765986155, TOPMed rs765986155, gnomAD rs765986155, REVEL 0.44, CADD 23.10
- G43S (p.Gly43Ser), ExAC rs765986155, TOPMed rs765986155, gnomAD rs765986155, REVEL 0.50, CADD 21.90
- S44T (p.Ser44Thr), gnomAD rs1940412753, REVEL 0.06, CADD 10.70
- G45D (p.Gly45Asp), rs1460706225, ClinGen CA384928328, ClinVar RCV001756866, gnomAD rs1460706225, REVEL 0.52, CADD 19.00, Uncertain significance, not provided
- G46A (p.Gly46Ala), TOPMed rs1445408084, gnomAD rs1445408084, REVEL 0.47, CADD 14.30
- G46S (p.Gly46Ser), 1000Genomes rs373935299, ESP rs373935299, ExAC rs373935299, gnomAD rs373935299, REVEL 0.35, CADD 20.40, Uncertain significance, Inborn genetic diseases
- G46V (p.Gly46Val), TOPMed rs1445408084, gnomAD rs1445408084, REVEL 0.37, CADD 14.80
- G48C (p.Gly48Cys), Ensembl rs1342631539, REVEL 0.46, CADD 16.60
- G49S (p.Gly49Ser), gnomAD rs1439509644, REVEL 0.26, CADD 13.60
- A50E (p.Ala50Glu), ExAC rs774980327, gnomAD rs774980327, REVEL 0.26, CADD 0.91
- A50T (p.Ala50Thr), rs762312695, NCI-TCGA Cosmic COSV5288, ExAC rs762312695, TOPMed rs762312695, REVEL 0.22, CADD 5.09, Variant assessed as somatic; moderate impact.
- C51R (p.Cys51Arg), gnomAD rs1416255263, REVEL 0.14, CADD 14.10
- G52E (p.Gly52Glu), rs1190770992, NCI-TCGA Cosmic COSV5288, NCI-TCGA Cosmic COSV9936, gnomAD rs1190770992, REVEL 0.51, CADD 16.90, Variant assessed as somatic; moderate impact.
- G53R (p.Gly53Arg), rs201156749, ClinGen CA6580925, ClinVar RCV003173083, ExAC rs201156749, REVEL 0.26, CADD 21.50, Uncertain significance, Inborn genetic diseases
- A54G (p.Ala54Gly), ExAC rs775438004, gnomAD rs775438004, REVEL 0.13, CADD 14.30
- A54V (p.Ala54Val), ExAC rs775438004, gnomAD rs775438004, REVEL 0.19, CADD 21.20, Uncertain significance, Inborn genetic diseases
- F56L (p.Phe56Leu), ExAC rs770002769, gnomAD rs770002769, REVEL 0.53, CADD 25.70
- G57S (p.Gly57Ser), NCI-TCGA Cosmic COSV5288, Variant assessed as somatic; moderate impact.
- R59C (p.Arg59Cys), ESP rs370887221, ExAC rs370887221, TOPMed rs370887221, gnomAD rs370887221, REVEL 0.27, CADD 23.70
- R59H (p.Arg59His), ExAC rs771831330, TOPMed rs771831330, gnomAD rs771831330, REVEL 0.12, CADD 21.90
- R59L (p.Arg59Leu), ExAC rs771831330, TOPMed rs771831330, gnomAD rs771831330, REVEL 0.18, CADD 21.80
- R59S (p.Arg59Ser), ESP rs370887221, ExAC rs370887221, TOPMed rs370887221, gnomAD rs370887221, REVEL 0.18, CADD 22.80
- S60R (p.Ser60Arg), TOPMed rs1404459768, gnomAD rs1404459768, REVEL 0.57, CADD 22.30, Likely benign
- Y62C (p.Tyr62Cys), Ensembl rs1592171353
- G63D (p.Gly63Asp), ExAC rs748772716, TOPMed rs748772716, gnomAD rs748772716, REVEL 0.45, CADD 4.34, Uncertain significance, Inborn genetic diseases
- G63S (p.Gly63Ser), TOPMed rs1940410961, REVEL 0.11, CADD 0.91
- L64M (p.Leu64Met), TOPMed rs1329443992, REVEL 0.04, CADD 10.70
- G65E (p.Gly65Glu), ExAC rs779449161, gnomAD rs779449161, REVEL 0.67, CADD 23.50
- G65R (p.Gly65Arg), NCI-TCGA TCGA novel, Ensembl rs1940410762, REVEL 0.62, CADD 24.00, Variant assessed as somatic; high impact.
- G65W (p.Gly65Trp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G66C (p.Gly66Cys), rs2498447682, ClinGen CA384928207, ClinVar RCV002748726, Uncertain significance, Inborn genetic diseases
- G66D (p.Gly66Asp), 1000Genomes rs562648897, ExAC rs562648897, TOPMed rs562648897, gnomAD rs562648897, REVEL 0.29, CADD 19.60
- G66V (p.Gly66Val), 1000Genomes rs562648897, ExAC rs562648897, TOPMed rs562648897, gnomAD rs562648897, REVEL 0.36, CADD 19.70
- S67F (p.Ser67Phe), TOPMed rs1479388107, gnomAD rs1479388107, REVEL 0.45, CADD 24.50
- K68R (p.Lys68Arg), NCI-TCGA Cosmic COSV5288, Variant assessed as somatic; moderate impact.
- R69T (p.Arg69Thr), TOPMed rs914504608, gnomAD rs914504608, REVEL 0.17, CADD 23.00
- I70F (p.Ile70Phe), 1000Genomes rs546022490, ExAC rs546022490, gnomAD rs546022490, REVEL 0.58, CADD 26.00, Uncertain significance
- I70L (p.Ile70Leu), 1000Genomes rs546022490, ExAC rs546022490, gnomAD rs546022490, REVEL 0.42, CADD 24.10, Uncertain significance, Inborn genetic diseases
- I70T (p.Ile70Thr), TOPMed rs1940410312, gnomAD rs1940410312, REVEL 0.54, CADD 24.60
- S71F (p.Ser71Phe), rs1203794781, gnomAD rs1203794781, REVEL 0.59, CADD 27.40, Variant assessed as somatic; moderate impact.
- I72N (p.Ile72Asn), 1000Genomes rs374536069, ESP rs374536069, ExAC rs374536069, gnomAD rs374536069, Uncertain significance
- I72T (p.Ile72Thr), rs374536069, ClinGen CA6580908, ClinVar RCV003179661, 1000Genomes rs374536069, REVEL 0.08, CADD 16.60, Uncertain significance, Inborn genetic diseases
- I72V (p.Ile72Val), ExAC rs764630392, gnomAD rs764630392, REVEL 0.02, CADD 13.20
- G73A (p.Gly73Ala), gnomAD rs1223468169, REVEL 0.02, CADD 11.30
- G73V (p.Gly73Val), gnomAD rs1223468169
- G74E (p.Gly74Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G75A (p.Gly75Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- S76R (p.Ser76Arg), TOPMed rs1392954643, gnomAD rs1392954643, REVEL 0.13, CADD 21.50
- S76T (p.Ser76Thr), gnomAD rs1305904902, REVEL 0.05, CADD 21.00
- A78D (p.Ala78Asp), ExAC rs752774038, TOPMed rs752774038, gnomAD rs752774038, REVEL 0.15, CADD 12.60
- A78G (p.Ala78Gly), NCI-TCGA Cosmic COSV9936, Variant assessed as somatic; moderate impact.
- A78V (p.Ala78Val), ExAC rs752774038, TOPMed rs752774038, gnomAD rs752774038, REVEL 0.14, CADD 6.83
- S80G (p.Ser80Gly), gnomAD rs1940409875, REVEL 0.06, CADD 0.00
- S80N (p.Ser80Asn), 1000Genomes rs560354778, ExAC rs560354778, TOPMed rs560354778, gnomAD rs560354778, REVEL 0.12, CADD 13.10
- G81A (p.Gly81Ala), ExAC rs776820315, gnomAD rs776820315, REVEL 0.28, CADD 13.00
- G81S (p.Gly81Ser), Ensembl rs1448552830, REVEL 0.21, CADD 10.80
- G82D (p.Gly82Asp), rs1389135889, ClinGen CA384928107, ClinVar RCV003248484, TOPMed rs1389135889, REVEL 0.52, CADD 20.90, Uncertain significance, Inborn genetic diseases
- G82S (p.Gly82Ser), rs761528539, ClinGen CA6580902, ClinVar RCV002769410, 1000Genomes rs761528539, REVEL 0.22, CADD 10.10, Uncertain significance, Inborn genetic diseases
- Y83N (p.Tyr83Asn), gnomAD rs1175394022, REVEL 0.25, CADD 17.10
- Y83S (p.Tyr83Ser), rs1468180571, ClinGen CA384928102, ClinVar RCV002743047, TOPMed rs1468180571, REVEL 0.12, CADD 15.60, Uncertain significance, Inborn genetic diseases
- G84D (p.Gly84Asp), rs774143030, ClinGen CA6580901, ClinVar RCV002708129, ExAC rs774143030, REVEL 0.52, CADD 21.80, Uncertain significance, Inborn genetic diseases
- G84S (p.Gly84Ser), rs1431332736, ClinGen CA384928097, ClinVar RCV004414422, TOPMed rs1431332736, REVEL 0.38, CADD 16.60, Uncertain significance, Inborn genetic diseases
- R86G (p.Arg86Gly), rs765830157, []
- A87D (p.Ala87Asp), TOPMed rs1940409274, REVEL 0.21, CADD 9.63
- A87S (p.Ala87Ser), TOPMed rs1940409297
- G88R (p.Gly88Arg), rs61914500, ClinGen CA6580899, ClinVar RCV003979749, ExAC rs61914500, REVEL 0.52, CADD 22.90, Benign, KRT6B-related disorder
- G88V (p.Gly88Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G89D (p.Gly89Asp), gnomAD rs1194903302, REVEL 0.22, CADD 18.30
- G89S (p.Gly89Ser), TOPMed rs1433215826, REVEL 0.05, CADD 16.60
- S90R (p.Ser90Arg), gnomAD rs1167700074
- G92A (p.Gly92Ala), rs1447172369, ClinGen CA384928040, ClinVar RCV004414423, gnomAD rs1447172369, REVEL 0.35, CADD 12.80, Uncertain significance, Inborn genetic diseases
- F93C (p.Phe93Cys), TOPMed rs1245349357, gnomAD rs1245349357, REVEL 0.12, CADD 16.40
- G94A (p.Gly94Ala), gnomAD rs1249045049, REVEL 0.39, CADD 15.20, Uncertain significance, Inborn genetic diseases
- A96S (p.Ala96Ser), ExAC rs769168555, gnomAD rs769168555, REVEL 0.21, CADD 13.60
- A96T (p.Ala96Thr), ExAC rs769168555, gnomAD rs769168555, REVEL 0.25, CADD 16.10
- A96V (p.Ala96Val), gnomAD rs1219929936, REVEL 0.18, CADD 10.90
- G97E (p.Gly97Glu), gnomAD rs1421255576, REVEL 0.36, CADD 15.00
- G97R (p.Gly97Arg), rs144860693, ClinGen CA6580896, ClinVar RCV001598256, ClinVar RCV003966241, REVEL 0.24, CADD 7.87, Benign, not provided
- S98G (p.Ser98Gly), NCI-TCGA Cosmic COSV9936, Variant assessed as somatic; moderate impact.
- S98N (p.Ser98Asn), 1000Genomes rs780990421, ExAC rs780990421, gnomAD rs780990421, REVEL 0.25, CADD 20.30, Uncertain significance, Inborn genetic diseases
- S98R (p.Ser98Arg), TOPMed rs1206463372, REVEL 0.45, CADD 10.40
- G99E (p.Gly99Glu), gnomAD rs1366130157, REVEL 0.47, CADD 21.60
- G99R (p.Gly99Arg), NCI-TCGA TCGA novel, Ensembl rs1940408492, REVEL 0.32, CADD 21.80, Variant assessed as somatic; moderate impact.
- F100L (p.Phe100Leu), TOPMed rs988699834, gnomAD rs988699834
- G101D (p.Gly101Asp), Ensembl rs1940408345
- G101S (p.Gly101Ser), ExAC rs756978054, gnomAD rs756978054, REVEL 0.32, CADD 19.20
- G103R (p.Gly103Arg), ExAC rs778306714, TOPMed rs778306714, gnomAD rs778306714, REVEL 0.37, CADD 19.80, Uncertain significance
- G103S (p.Gly103Ser), rs778306714, ClinGen CA6580892, ClinVar RCV003391841, ClinVar RCV004985358, REVEL 0.26, CADD 14.70, Uncertain significance, not provided; Inborn genetic diseases
- G104A (p.Gly104Ala), gnomAD rs1416806354, REVEL 0.29, CADD 1.42
- G104D (p.Gly104Asp), gnomAD rs1416806354, REVEL 0.50, CADD 9.39
- G104S (p.Gly104Ser), gnomAD rs1409247838
- G104V (p.Gly104Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G107R (p.Gly107Arg), 1000Genomes rs765830157, ExAC rs765830157, gnomAD rs765830157, REVEL 0.53, CADD 17.40
- G107S (p.Gly107Ser), 1000Genomes rs765830157, ExAC rs765830157, gnomAD rs765830157, REVEL 0.38, CADD 11.60, Uncertain significance, Inborn genetic diseases
- G109A (p.Gly109Ala), Ensembl rs1281671312
- G111D (p.Gly111Asp), rs61745883, ClinGen CA6580888, ClinVar RCV000602544, ClinVar RCV003983144, REVEL 0.62, CADD 22.70, Benign, Pachyonychia congenita 2; not provided
- G113D (p.Gly113Asp), Ensembl rs1940407775, REVEL 0.58, CADD 24.40
- G114D (p.Gly114Asp), ExAC rs753917253, gnomAD rs753917253, REVEL 0.62, CADD 22.70
- G115E (p.Gly115Glu), rs574747070, ClinGen CA6580885, ClinVar RCV002794404, 1000Genomes rs574747070, REVEL 0.61, CADD 23.50, Uncertain significance, Inborn genetic diseases
- G115R (p.Gly115Arg), ExAC rs766529656, gnomAD rs766529656, REVEL 0.61, CADD 24.10
- A116S (p.Ala116Ser), gnomAD rs1243559179
- A116T (p.Ala116Thr), gnomAD rs1243559179, REVEL 0.35, CADD 14.50
- G117A (p.Gly117Ala), ExAC rs774088015, TOPMed rs774088015, gnomAD rs774088015, REVEL 0.48, CADD 16.40, Uncertain significance
- G117D (p.Gly117Asp), rs774088015, ClinGen CA6580884, ClinVar RCV003366251, ExAC rs774088015, REVEL 0.68, CADD 17.60, Uncertain significance, Inborn genetic diseases
- G117S (p.Gly117Ser), gnomAD rs1303170282, REVEL 0.53, CADD 17.40
- L118F (p.Leu118Phe), gnomAD rs1352637124, REVEL 0.15, CADD 10.30
Public KRT6B analysis runs
- KRT6B analysis run — KRT6B (1,119 variants) — completed 2026-08-22